PB1762 A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY PLUS MIDOSTAURIN (PKC412) OR PLACEBO IN NEWLY DIAGNOSED PATIENTS WITH FLT3 MUTATION NEGATIVE AML
Keyword(s):
Keyword(s):
2007 ◽
Vol 57
(6)
◽
pp. 501
Keyword(s):
2010 ◽
Vol 65
(Supplement 4)
◽
pp. iv41-iv51
◽
Keyword(s):
Keyword(s):
2000 ◽
Vol 22
(12)
◽
pp. 1421-1432
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 147
(9)
◽
pp. 2493-2502
◽
Keyword(s):
2000 ◽
Vol 22
(12)
◽
pp. 1410-1420
◽
Keyword(s):